Amidst global economic uncertainties and fluctuating trade policies, Asian markets have shown resilience, with varying impacts on indices across the region. This environment presents opportunities for discerning investors to explore stocks that may be trading below their intrinsic value, particularly those with strong fundamentals and potential for growth despite external pressures.

Name

Current Price

Fair Value (Est)

Discount (Est)

Xi’an NovaStar Tech (SZSE:301589)

CNÂ¥155.51

CNÂ¥309.46

49.7%

SpiderPlus (TSE:4192)

Â¥506.00

Â¥997.79

49.3%

Ningbo Sanxing Medical ElectricLtd (SHSE:601567)

CNÂ¥22.88

CNÂ¥45.72

50%

Nanya Technology (TWSE:2408)

NT$43.75

NT$87.13

49.8%

Nan Ya Printed Circuit Board (TWSE:8046)

NT$176.50

NT$350.51

49.6%

Insource (TSE:6200)

Â¥926.00

Â¥1843.53

49.8%

H.U. Group Holdings (TSE:4544)

Â¥3254.00

Â¥6446.96

49.5%

Elan (TSE:6099)

Â¥850.00

Â¥1696.06

49.9%

cottaLTD (TSE:3359)

Â¥441.00

Â¥871.25

49.4%

Astroscale Holdings (TSE:186A)

Â¥676.00

Â¥1333.68

49.3%

Click here to see the full list of 274 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let’s take a closer look at a couple of our picks from the screened companies.

Overview: Beijing HyperStrong Technology Co., Ltd. designs, develops, integrates, and operates energy storage power stations across China, Europe, North America, and Australia with a market cap of CNÂ¥16.64 billion.

Operations: The company’s revenue segments include the design, development, integration, and operation of energy storage power stations across its key markets in China, Europe, North America, and Australia.

Estimated Discount To Fair Value: 37.2%

Beijing HyperStrong Technology is trading at CNÂ¥92.37, significantly below its estimated fair value of CNÂ¥147.06, suggesting it may be undervalued based on cash flows. Its revenue and earnings are forecast to grow over 30% annually, outpacing the Chinese market’s growth rates. However, its dividend yield of 1.19% is not well covered by free cash flows. Recent innovations like the HyperBlock M enhance its competitive edge in energy storage solutions through modularity and efficiency improvements.

SHSE:688411 Discounted Cash Flow as at Aug 2025 SHSE:688411 Discounted Cash Flow as at Aug 2025

Overview: Shenzhen KSTAR Science and Technology Co., Ltd. operates in the technology sector, focusing on power electronics and renewable energy solutions, with a market cap of CNÂ¥13.86 billion.

繼續閱讀

Operations: Unfortunately, the provided text does not contain specific revenue segment information for Shenzhen KSTAR Science and Technology Co., Ltd.

Estimated Discount To Fair Value: 48.5%

Shenzhen KSTAR Science and Technology is trading at CNÂ¥23.8, well below its estimated fair value of CNÂ¥46.24, indicating potential undervaluation based on cash flows. The company’s revenue is projected to grow 22.3% annually, surpassing the Chinese market’s average growth rate. Despite a forecasted earnings growth of 32.4%, profit margins have declined from last year, and the dividend track record remains unstable with recent reductions in payouts for 2024 dividends.

SZSE:002518 Discounted Cash Flow as at Aug 2025 SZSE:002518 Discounted Cash Flow as at Aug 2025

Overview: Qingdao Baheal Medical INC. is involved in the research, development, production, wholesale, and retail of pharmaceutical products across China, the United States, Hong Kong, and the United Kingdom with a market cap of CNÂ¥11.77 billion.

Operations: Qingdao Baheal Medical INC. generates revenue through its activities in the research, development, production, wholesale, and retail sectors of pharmaceutical products across several international markets including China, the United States, Hong Kong, and the United Kingdom.

Estimated Discount To Fair Value: 18.5%

Qingdao Baheal Medical, trading at CNÂ¥22.39, is priced below its fair value estimate of CNÂ¥27.46, reflecting potential undervaluation based on cash flows. Despite a volatile share price recently, earnings are projected to grow significantly at 20.05% annually over the next three years, although this lags behind the broader Chinese market’s growth rate. The company affirmed a dividend payout for 2024, which may appeal to income-focused investors amid stable revenue growth projections of 13% per year.

SZSE:301015 Discounted Cash Flow as at Aug 2025 SZSE:301015 Discounted Cash Flow as at Aug 2025

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SHSE:688411 SZSE:002518 and SZSE:301015.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com